bw-755c has been researched along with Ventricular Fibrillation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bohle, RM; Buchwald, A; Klein, HH; Kreuzer, H; Lindert, S; Nebendahl, K; Pich, S; Schuff-Werner, P | 1 |
Cooper, DR; Kelliher, GJ; Kowey, PR | 1 |
2 other study(ies) available for bw-755c and Ventricular Fibrillation
Article | Year |
---|---|
Antiinflammatory agent BW 755 C in ischemic reperfused porcine hearts.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Anesthesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Hemoglobins; In Vitro Techniques; Leukocyte Count; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Pyrazoles; Swine; Ventricular Fibrillation | 1988 |
Modulation of arachidonic acid metabolites and vulnerability to ventricular fibrillation during myocardial ischemia in the cat.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Cardiac Pacing, Artificial; Cats; Chromones; Coronary Disease; Female; Male; Naphthoquinones; ortho-Aminobenzoates; Pyrazoles; SRS-A; Sulfinpyrazone; Ventricular Fibrillation | 1988 |